Concurrent Drug Utilization Review definition
Concurrent Drug Utilization Review is a series of edits at the point-of-service that are applied to a prescription drug claim comparing member information with the drug dispensed and information in the database related to other medications the member is taking.
Concurrent Drug Utilization Review. (CDUR) is a program designed to measure and to assess the proper use of medication based on predetermined standards. Used to ensure correct prescribing by detecting inappropriate or unnecessary drug therapy through edits monitoring individual drugs, drug classes or specified disease. CDUR also includes encouragement of and the awareness of opportunities for the substitution of generic drugs for brand drugs when of equal therapeutic value.
Concurrent Drug Utilization Review. (“DUR”) shall mean the algorithm systematically applied at a Participating Pharmacy before dispensing that considers the Presenting Drug’s safety and efficacy in context with other drugs that have been dispensed. In addition, the algorithm includes applicable protocols and guidelines based on the Presenting Drug and specific claim history, such as the time period from the last fill of the same Drug.
Examples of Concurrent Drug Utilization Review in a sentence
Included Concurrent Drug Utilization Review: Real time point of sale monitoring for potential medication use conflicts Included Basic Fraud, ▇▇▇▇▇ & Abuse Audit: Optum staffs a diverse team of auditors and investigators focused on generating recoveries for, and detecting and deterring, fraud on the behalf of the client.
Connection (Concurrent Drug Utilization Review) Connection works with the retail pharmacy’s standard guidelines to provide a second level of quality and safety checks.
Administrator will provide Concurrent Drug Utilization Review, Prior Authorization, and Clinical Communication services described in Attachment B (PBM Services) of the Agreement.
More Definitions of Concurrent Drug Utilization Review
Concurrent Drug Utilization Review or “Concurrent DUR” means the review of drug utilization when an On-Line Claim is processed by Aetna at the point of sale.
Concurrent Drug Utilization Review. (“DUR”) shall mean the algorithm systematically applied at a network pharmacy before dispensing that considers the Presenting Drug’s safety and efficacy in context with other drugs that have been dispensed. In addition, the algorithm includes applicable protocols and guidelines based on the Presenting Drug and specific patient characteristics such as allergies.
Concurrent Drug Utilization Review or “Concurrent DUR” means the review of drug utilization when an On‐ Line Claim is processed by Aetna at the point of sale.